The holiday season has arrived and earnings season too — and here are the highlights for 10 bellwether bioeconomy publicly-traded stocks.
Aemetis – ethanol prices dive, but cellulosic on the way
Avantium – IPO completed, Synvia next, then Zambezi
BioAmber – “bumpy road continues”; cost focus, Sarnia expansion
Calyxt – on track for soybean commercial launch in 2018
Codexis – product sales up 71% off low base
Gevo – as market development for marine isobutanol continues, looking to recap
Green Plains – diversification provides a dividend
Novozymes – upgrading 2017 guidance or stronger organic growth, especially in food/beverages and bioenergy
Pacific Ethanol – ethanol prices dive, 2018 looms with positives
REG – loss of tax credit means swing to loss, but product, RIN prices rise
Here are the 10 bellwether bioeconomy reports that have come in.